3.51
3.51 (0%)
As of Feb 14, 2025
Agenus Inc [AGEN]
Source:
Company Overview
Agenus Inc is a clinical-stage biotechnology company specializing in discovering and developing therapies to activate the body's immune system against cancer and infections.
| Country | United States |
| Headquarters | lexington, massachusetts |
| Phone Number | 781-674-4410 |
| Industry | manufacturing |
| CEO | Garo H. Armen |
| Website | www.agenusbio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $103.5 |
| Operating Profit | $-120.5 |
| Net Income | $-232.3 |
| Net Cash | $-35.7 |
Profit Ratios
| Gross Margin | $103.9 |
| Operating Margin | -116.4 |
| Profit as % of Revenues | -44.8% |
| Profit as % of Assets | -86% |
| Profit as % of Stockholder Equity | 75.8% |
Management Effectiveness
| Return on Equity | 75.8% |
| Return on Assets | -102.7% |
| Turnover Ratio | 38.3% |
| EBITA | $-120.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $226.3 |
| Total Liabilities | $532.7 |
| Operating Cash Flow | $-158.3 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $122.8 |
